This site is intended for healthcare professionals only
LoginRegister
Marksans Pharma Gets USFDA Nod for Generic Tessalon CapsulesMarksans Pharma Gets USFDA Nod for Generic Tessalon Capsules
Zydus Lifesciences Slapped Rs 1.42 Crore Tax Demand, Plans to Challenge OrderZydus Lifesciences Slapped Rs 1.42 Crore Tax Demand, Plans to Challenge Order
J.B. Chemicals CEO Nikhil Chopra ResignsJ.B. Chemicals CEO Nikhil Chopra Resigns
NPPA Revises Ceiling Prices of 138 Essential Drugs with WPI-Linked Hike Effective April 1NPPA Revises Ceiling Prices of 138 Essential Drugs with WPI-Linked Hike Effective April 1
Eris Lifesciences Asked to Revise Phase IV Protocol for Dapagliflozin, Gliclazide, Metformin FDCEris Lifesciences Asked to Revise Phase IV Protocol for Dapagliflozin, Gliclazide, Metformin FDC
USFDA Pulls Up ImmunityBio Over Misleading Claims for Cancer Drug ANKTIVAUSFDA Pulls Up ImmunityBio Over Misleading Claims for Cancer Drug ANKTIVA
Granules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action RequiredGranules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action Required
Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC IrregularitiesZydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC Irregularities
Lupin Gets USFDA Tentative Approval for Generic Anesthesia Reversal Drug SugammadexLupin Gets USFDA Tentative Approval for Generic Anesthesia Reversal Drug Sugammadex
Kenvue Defends ORSL, ERZL Amid Misinformation Concerns, Reaffirms Science-Backed Hydration StrategyKenvue Defends ORSL, ERZL Amid Misinformation Concerns, Reaffirms Science-Backed Hydration Strategy
Mercks Enlicitide Outperforms Rivals in Cutting Bad Cholesterol in Late-Stage TrialMerck's Enlicitide Outperforms Rivals in Cutting Bad Cholesterol in Late-Stage Trial
Govt Mulls Invoking Essential Commodities Act as Supply Disruptions Push API Costs Up to 300 pcGovt Mulls Invoking Essential Commodities Act as Supply Disruptions Push API Costs Up to 300%
X